T1	Condition 77 89	hypotenstion
T2	Condition 93 98	shock
T3	Condition 100 105	ileus
T4	Condition 109 126	bowel obstruction
T5	Condition 128 137	megacolon
T6	Non-query-able 0 75	Patients with severe-complicated disease that would compromise oral therapy
*	OR T1 T2 T3 T4 T5
T7	Condition 158 165	allergy
T8	Drug 174 184	vancomycin
T9	Drug 188 199	fidaxomicin
T10	Qualifier 169 173	oral
R1	Has_qualifier Arg1:T8 Arg2:T10	
*	OR T8 T9
T11	Scope 174 199	vancomycin or fidaxomicin
R2	Has_scope Arg1:T7 Arg2:T11	
T12	Drug 234 247	metronidazole
T13	Mood 211 222	anticipated
R3	Has_mood Arg1:T12 Arg2:T13	
T14	Drug 302 312	vancomycin
T15	Drug 316 329	metronidazole
T16	Qualifier 297 301	oral
R4	Has_qualifier Arg1:T14 Arg2:T16	
*	OR T14 T15
T17	Multiplier 363 373	> 24 hours
T18	Temporal 385 430	preceding 72 hours at the time of enrollment.
T19	Reference_point 419 429	enrollment
R5	Has_index Arg1:T18 Arg2:T19	
T20	Scope 297 329	oral vancomycin or metronidazole
R6	Has_multiplier Arg1:T20 Arg2:T17	
T21	Mood 441 452	anticipated
T22	Procedure 475 495	C. difficile therapy
T23	Drug 497 506	rifaxamin
T24	Drug 508 520	nitazoxanide
T25	Drug 522 533	tigecycline
*	OR T23 T24 T25
T26	Scope 497 534	rifaxamin, nitazoxanide, tigecycline)
R7	Subsumes Arg1:T22 Arg2:T26	
R8	Has_mood Arg1:T22 Arg2:T21	
